Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Income from Continuing Operations (2019 - 2025)

Outset Medical (OM) has disclosed Income from Continuing Operations for 7 consecutive years, with 19491000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 23.98% to 19491000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 81653000.0, a 36.2% increase, with the full-year FY2025 number at 81653000.0, up 36.2% from a year prior.
  • Income from Continuing Operations was 19491000.0 for Q4 2025 at Outset Medical, down from 17838000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 17838000.0 in Q3 2025 to a low of 46180000.0 in Q3 2023.
  • A 5-year average of 33865850.0 and a median of 35673000.0 in 2022 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 45.4% in 2021, then skyrocketed 46.19% in 2025.
  • Outset Medical's Income from Continuing Operations stood at 41232000.0 in 2021, then dropped by 0.51% to 41444000.0 in 2022, then increased by 6.86% to 38600000.0 in 2023, then surged by 33.58% to 25638000.0 in 2024, then increased by 23.98% to 19491000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Income from Continuing Operations are 19491000.0 (Q4 2025), 17838000.0 (Q3 2025), and 18541000.0 (Q2 2025).